Hjem › Lupus nefritis › Texas
Lupus nefritis kliniske forsøg i Texas
12 studier for Lupus nefritis søger deltagere på steder i Texas.
Byer i Texas
Officiel studietekst (engelsk)
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Prolato Clinical Research Center, Houston
RekruttererFase 2
Alder 18 til 100 · Alle køn · Opdateret 1. okt. 2026 · NCT05268289Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
- Baylor College of Medicine, Houston
RekruttererFase 1
Alder 18 til 60 · Alle køn · Opdateret 14. sep. 2026 · NCT06975787The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
- Baylor College of Medicine Pediatric Immunology Allergy Rheumatology, Houston
RekruttererFase 2
Alder 8 til 20 · Alle køn · Opdateret 14. sep. 2026 · NCT05538208A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- The University of Texas Southwestern Medical Center, Dallas
RekruttererFase 2
Alder 12 til 70 · Alle køn · Opdateret 14. sep. 2026 · NCT07570862RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of Texas MD Anderson Cancer Center, Houston
RekruttererFase 1/2
Alder 18 til 65 · Alle køn · Opdateret 26. aug. 2026 · NCT06121297Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
- Texas Transplant Institute, San Antonio
RekruttererFase 2
Alder 12 til 65 · Alle køn · Opdateret 24. aug. 2026 · NCT07053800PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
- Novel Research LLC, Bellaire
- Liberty Research Center, Dallas
- Texas Arthritis Center, El Paso
- og 5 flere
RekruttererFase 4
Alder 18 til 75 · Alle køn · Opdateret 3. aug. 2026 · NCT07611214A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
- Rheumatology Care Center, PLLC, Bellaire
- Texas Arthritis Center, El Paso
- Novel Research, LLC., Houston
- og 3 flere
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 30. jul. 2026 · NCT07201129A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
- Nkarta Investigational Site, Dallas
- Nkarta Investigational Site, Houston
RekruttererFase 1/2
Alder 18 til 75 · Alle køn · Opdateret 4. jun. 2026 · NCT06557265Lupus Landmark Study: A Prospective Registry and Biorepository
- UT Southwestern Medical Center, Dallas
RekruttererObservationsstudie
Alder 18 til 110 · Alle køn · Opdateret 15. apr. 2026 · NCT05934149Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 15. apr. 2026 · NCT06434363Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
- AARA Clinical Research, Fort Worth
RekruttererFase 4
Alder 18 til 80 · Alle køn · Opdateret 6. nov. 2025 · NCT07225387Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.